Skip to content
DraconiticResearch
Search Sources API
211,646 studies31 sourcesUpdated 31 min ago

Oncology

5,331 studies510 in 7 days2,567 in 30 days

Filters
Type
Date
Clear

Latest

5,331 studies

  1. Plasma Carrier Proteins as Supramolecular Nanovectors for Cancer Therapy: The Trojan Horse Approach
    Alessia Marconi, Andrea Carboni, Matteo Di Giosia +1
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  2. Advanced Therapies for the Management of Immune Checkpoint Inhibitor-Induced Colitis
    Cosimo Simone Matichecchia, Fabrizio Fanizzi, Alessandra Zilli +7
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  3. Distinct Molecular Landscape and Clinical Subtype of HPV-Positive Esophageal Squamous Cell Carcinoma
    Hang Li, Xuxia Shen, Yan Jin +3
    CancersPeer-reviewedCC BYFull textOncologyEurope PMC
  4. CReP-mediated control of eIF2α phosphorylation is a critical node in MYC-driven medulloblastoma
    Liliana Mirabal-Ortega, Sandra Majo, Lucie J Taunay +31
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyHAL
  5. Compartmentalisation of death receptor signalling in cancer
    Victoria Maltret, Elodie Lafont
    OncogenesisPeer-reviewedCC BY 4.0Full textOncologyHAL
  6. Single-cell transcriptome profiling of post-treatment and treatment-naïve colorectal cancer: Insights into putative mechanisms of chemoresistance
    Grigory Puzanov, Clémence Astier, Dimitris Papakonstantinou +9
    Cancer LettersPeer-reviewedCC BY 4.0Full text5 citedOncologyHAL
  7. Pregnane X receptor deletion induces a lean phenotype in chow-fed mice through a liver–ileum–muscle axis involving 6α-hydroxylated bile acids and Fgf15
    Bérengère Benoit, Audrey Jalabert, Emmanuelle Meugnier +16
    Molecular metabolismPeer-reviewedCC BYFull textOncologyHAL
  8. Hepatocytes promote liver metastasis of pancreatic cancer by providing serine
    Koelina Ganguly, Keisuke Yamamoto, Jason Rodencal +15
    NaturePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  9. Exploring Primary Care Interventions to Increase Lung, Breast, and Cervical Cancer Screening With Individuals Experiencing Marginalization: A Scoping Review
    Etta Jantzen, Janina Althea Quiambao, Dominick LeBlanc +5
    Cancer Control: Journal of the Moffitt Cancer CenterPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  10. Associations of County-Level Urbanicity With Overall Survival Across 19 Solid Tumor Groups, 2004–2023: A SEER Cohort Study of 5.5 Million Patients
    Lihui Liang, Jiancheng Huang, Qingbai Jiang
    Cancer Control: Journal of the Moffitt Cancer CenterPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  11. Multiomics analysis identifies RNASET2 as a potential candidate target associated with lung adenocarcinoma
    Yue Shi, Jiankun Yang, Fangyu Cai +9
    The Journal of International Medical ResearchPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  12. BAP1 loss and PRAME expression converge to remodel the tumor-immune ecosystem during uveal melanoma progression
    J. J. Dollar, X. Liu, M. Singh +7
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  13. Prognostic value, signal interaction network, and immune infiltration characteristics of MET gene expression in gastric cancer analyzed by multi-database bioinformatics
    Z. Zhang, X. Wei
    bioRxivPreprintCC BYFull textOncologybioRxiv
  14. A plasma metabolomics workflow for breast cancer detection using quantitative GC/MS and machine learning
    N. Ojima, T. Yokoyama, S. Nishiumi +11
    bioRxivPreprintCC BYFull textOncologybioRxiv
  15. A Research-Integrated Curriculum on CAR-T Cell Therapy
    Y. H. Khan, L. Rice, M. C. Srougi
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  16. Metabolic engineering of Salmonella enterica for coupled kynurenine sensing and depletion enhances antitumor efficacy
    K. K. Varsha, A. Santos, T. Xiao +11
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  17. Cellular uptake of folate-olaparib conjugates via folate receptor-mediated endocytosis: Potential for selective delivery of DNA damage response inhibitors into tumour cells
    V. Bavetsias, L. Pickard, S. Diaz-Sanchez +12
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  18. GTP biosynthesis is a therapeutic vulnerability in Rac1-mutant melanoma
    S. Eugin Simon, T. Wang, A. Sreekumar +6
    bioRxivPreprintCC BYFull textOncologybioRxiv
  19. Somatic DDX41 mutations confer neomorphic splicing activity in the pathogenesis of myelodysplastic neoplasms
    R. Venkataraman, N. Puccio, T.-Y. Hsueh +21
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  20. AR-V7 Utilizes a Noncanonical Nuclear Localization Signal to Sustain Androgen-Independent Nuclear Import and Signaling
    U. del Castillo, N. E. Abou-Ghali, C. Burdette +7
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  21. Glucocorticoid receptor activation reorganizes Wnt/LEF1 regulatory circuitry associated with therapeutic response in B-cell acute lymphoblastic leukemia
    R. J. Mobley, D. Oluwalana, G. Baniulyte +15
    bioRxivPreprintCC BYFull textOncologybioRxiv
  22. ONC201 in combination with ATR inhibitor ceralasertib exhibits potent synergy in ovarian cancer cells
    M. Ghandali, K. M. Selvi, K. Huntington +6
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  23. Impact of Realistic 3D Tumor Microarchitecture on Cellular Dosimetry and Radiobiological Response in Targeted Radionuclide Therapy
    T. A. Peirispulle, R. Ware, S. Korevaar +3
    bioRxivPreprintCC BYFull textOncologybioRxiv
  24. Topotecan Syndergizes with SP141 in the Management of Uveal Melanoma
    A. Thomas, U. R. Addi, A. Wu +5
    bioRxivPreprintCC BY-NDFull textOncologybioRxiv
  25. Metabolic-epigenetic coupling between leucine catabolism and glycolysis drives CDK4/6 inhibitor resistance
    M. U. Oliphant, K. Norton, K. Kurmi +8
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv